KRON Financial Statements

Balance sheet, income statement, cash flow, and dividends for Kronos Bio Inc (KRON).


$57.32M Market Cap.

As of 03/19/2025 5:00 PM ET (MRY) • Disclaimer

KRON Market Cap. (MRY)


KRON Shares Outstanding (MRY)


KRON Assets (MRY)


Total Assets

$124.36M

Total Liabilities

$36.78M

Total Investments

$27.85M

KRON Income (MRY)


Revenue

$9.85M

Net Income

-$86.08M

Operating Expense

$102.73M

KRON Cash Flow (MRY)


CF Operations

-$65.44M

CF Investing

$85.44M

CF Financing

$245.00K

KRON Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

KRON Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$124,363,000 (-41.69%)

$213,279,000 (-27.69%)

$294,938,000 (-24.66%)

$391,476,000 (-23.53%)

Assets Current

$115,228,000 (-35.55%)

$178,778,000 (-26.82%)

$244,291,000 (-29.71%)

$347,554,000 (-17.21%)

Assets Non-Current

$9,135,000 (-73.52%)

$34,501,000 (-31.88%)

$50,647,000 (15.31%)

$43,922,000 (-52.34%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$87,580,000 (-44.95%)

$159,078,000 (-34.94%)

$244,499,000 (-29.15%)

$345,097,000 (-25.87%)

Property Plant & Equipment Net

$6,997,000 (-76.61%)

$29,909,000 (-20.65%)

$37,692,000 (-9.79%)

$41,784,000 (1.99%)

Cash & Equivalents

$86,597,000 (30.51%)

$66,352,000 (-14.93%)

$77,999,000 (-61.06%)

$200,296,000 (-19.89%)

Accumulated Other Comprehensive Income

$9,000 (-52.63%)

$19,000 (102.40%)

-$792,000 (-1930.77%)

-$39,000 (-105.26%)

Deferred Revenue

$1,864,000 (-86.41%)

$13,711,000 (0%)

$0 (0%)

$0 (0%)

Total Investments

$27,851,000 (-74.83%)

$110,660,000 (-35.65%)

$171,974,000 (21.76%)

$141,239,000 (-34.02%)

Investments Current

$27,851,000 (-74.37%)

$108,671,000 (-33.01%)

$162,212,000 (14.85%)

$141,239,000 (-14.43%)

Investments Non-Current

$0 (0%)

$1,989,000 (-79.63%)

$9,762,000 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$2,402,000 (172.03%)

$883,000 (-82.50%)

$5,047,000 (405.71%)

$998,000 (-78.07%)

Accumulated Retained Earnings (Deficit)

-$594,940,000 (-16.92%)

-$508,861,000 (-28.44%)

-$396,188,000 (-50.65%)

-$262,984,000 (-135.00%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$24,900,000 (-11.93%)

$28,272,000 (-9.07%)

$31,091,000 (-7.91%)

$33,762,000 (5.32%)

Debt Current

$3,394,000 (17.32%)

$2,893,000 (23.26%)

$2,347,000 (11.28%)

$2,109,000 (125.08%)

Debt Non-Current

$21,506,000 (-15.26%)

$25,379,000 (-11.71%)

$28,744,000 (-9.19%)

$31,653,000 (1.71%)

Total Liabilities

$36,783,000 (-32.14%)

$54,201,000 (7.46%)

$50,439,000 (8.75%)

$46,379,000 (-0.14%)

Liabilities Current

$15,277,000 (-38.14%)

$24,695,000 (14.94%)

$21,486,000 (57.68%)

$13,626,000 (5.99%)

Liabilities Non-Current

$21,506,000 (-27.11%)

$29,506,000 (1.91%)

$28,953,000 (-11.60%)

$32,753,000 (-2.49%)

KRON Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$9,848,000 (56.62%)

$6,288,000 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$24,616,000 (-41.02%)

$41,739,000 (-3.83%)

$43,400,000 (12.74%)

$38,495,000 (160.21%)

Research & Development Expense

$48,664,000 (-43.66%)

$86,379,000 (-7.83%)

$93,715,000 (-17.00%)

$112,903,000 (161.05%)

Operating Expenses

$102,735,000 (-19.81%)

$128,118,000 (-6.56%)

$137,115,000 (-9.43%)

$151,398,000 (160.83%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$86,079,000 (23.60%)

-$112,673,000 (15.41%)

-$133,204,000 (11.83%)

-$151,078,000 (-70.82%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$86,079,000 (23.60%)

-$112,673,000 (15.41%)

-$133,204,000 (11.83%)

-$151,078,000 (-70.82%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$86,079,000 (23.60%)

-$112,673,000 (15.41%)

-$133,204,000 (11.83%)

-$151,078,000 (-70.82%)

Weighted Average Shares

$60,070,000 (4.03%)

$57,744,000 (2.74%)

$56,201,398 (2.64%)

$54,753,599 (236.38%)

Weighted Average Shares Diluted

$60,070,000 (4.03%)

$57,744,000 (2.74%)

$56,201,398 (2.64%)

$54,753,599 (236.38%)

Earning Before Interest & Taxes (EBIT)

-$86,079,000 (23.60%)

-$112,673,000 (15.41%)

-$133,204,000 (11.83%)

-$151,078,000 (-78.68%)

Gross Profit

$9,848,000 (56.62%)

$6,288,000 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$92,887,000 (23.76%)

-$121,830,000 (11.15%)

-$137,115,000 (9.43%)

-$151,398,000 (-160.83%)

KRON Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$85,435,000 (28.73%)

$66,368,000 (305.97%)

-$32,222,000 (-150.56%)

$63,724,000 (139.77%)

Net Cash Flow from Financing

$245,000 (-56.79%)

$567,000 (-33.37%)

$851,000 (-80.92%)

$4,460,000 (-98.93%)

Net Cash Flow from Operations

-$65,435,000 (16.73%)

-$78,582,000 (13.58%)

-$90,926,000 (22.89%)

-$117,924,000 (-211.05%)

Net Cash Flow / Change in Cash & Cash Equivalents

$20,245,000 (273.82%)

-$11,647,000 (90.48%)

-$122,297,000 (-145.87%)

-$49,740,000 (-122.87%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$85,439,000 (27.43%)

$67,047,000 (311.87%)

-$31,645,000 (-146.55%)

$67,984,000 (145.12%)

Capital Expenditure

-$4,000 (99.41%)

-$679,000 (-17.68%)

-$577,000 (86.46%)

-$4,260,000 (55.48%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

-$5,000 (-100.00%)

Issuance (Purchase) of Equity Shares

$245,000 (-56.79%)

$567,000 (-33.37%)

$851,000 (-80.94%)

$4,465,000 (-98.31%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$9,217,000 (-63.11%)

$24,982,000 (-19.79%)

$31,145,000 (18.82%)

$26,211,000 (598.40%)

Depreciation Amortization & Accretion

$1,716,000 (-65.09%)

$4,916,000 (10.15%)

$4,463,000 (9.36%)

$4,081,000 (-16.13%)

KRON Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00%

-

-

Profit Margin

-874.10% (51.22%)

-1791.90%

-

-

EBITDA Margin

-856.70% (50.01%)

-1713.70%

-

-

Return on Average Equity (ROAE)

-75.00% (-27.55%)

-58.80% (-23.79%)

-47.50% (-26.67%)

-37.50% (6.25%)

Return on Average Assets (ROAA)

-55.40% (-23.11%)

-45.00% (-11.39%)

-40.40% (-20.24%)

-33.60% (-16.67%)

Return on Sales (ROS)

-874.10% (51.22%)

-1791.90%

-

-

Return on Invested Capital (ROIC)

-91.40% (-58.96%)

-57.50% (-6.28%)

-54.10% (-0.93%)

-53.60% (-10.74%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.66 (-3.59%)

-0.64 (6.29%)

-0.68 (86.11%)

-4.92 (10.49%)

Price to Sales Ratio (P/S)

5.79 (-49.52%)

11.48

-

-

Price to Book Ratio (P/B)

0.66 (43.01%)

0.46 (21.49%)

0.38 (-83.01%)

2.22 (-38.28%)

Debt to Equity Ratio (D/E)

0.42 (23.17%)

0.34 (65.53%)

0.21 (53.73%)

0.13 (34.00%)

Earnings Per Share (EPS)

-1.43 (26.67%)

-1.95 (17.72%)

-2.37 (14.13%)

-2.76 (49.17%)

Sales Per Share (SPS)

0.16 (50.46%)

0.11 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.09 (20.68%)

-1.37 (15.66%)

-1.63 (27.06%)

-2.23 (23.48%)

Book Value Per Share (BVPS)

1.46 (-47.08%)

2.75 (-36.67%)

4.35 (-30.99%)

6.3 (-77.96%)

Tangible Assets Book Value Per Share (TABVPS)

2.07 (-43.96%)

3.69 (-29.61%)

5.25 (-26.60%)

7.15 (-77.27%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

0 (0%)

-4 (80.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.07 (81.61%)

-0.4 (6.15%)

-0.42 (89.29%)

-3.95 (81.70%)

Asset Turnover

0.06 (152.00%)

0.03 (0%)

0 (0%)

0 (0%)

Current Ratio

7.54 (4.20%)

7.24 (-36.33%)

11.37 (-55.42%)

25.51 (-21.89%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$65,439,000 (17.44%)

-$79,261,000 (13.38%)

-$91,503,000 (25.11%)

-$122,184,000 (-157.34%)

Enterprise Value (EV)

$6,131,872 (-85.68%)

$42,812,650 (-21.35%)

$54,433,366 (-90.63%)

$580,794,617 (-66.24%)

Earnings Before Tax (EBT)

-$86,079,000 (23.60%)

-$112,673,000 (15.41%)

-$133,204,000 (11.83%)

-$151,078,000 (-70.82%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$84,363,000 (21.71%)

-$107,757,000 (16.30%)

-$128,741,000 (12.42%)

-$146,997,000 (-84.47%)

Invested Capital

$47,389,000 (-68.51%)

$150,504,000 (-33.57%)

$226,544,000 (7.21%)

$211,316,000 (-24.83%)

Working Capital

$99,951,000 (-35.13%)

$154,083,000 (-30.84%)

$222,805,000 (-33.28%)

$333,928,000 (-17.94%)

Tangible Asset Value

$124,363,000 (-41.69%)

$213,279,000 (-27.69%)

$294,938,000 (-24.66%)

$391,476,000 (-23.53%)

Market Capitalization

$57,323,872 (-21.36%)

$72,895,650 (-20.92%)

$92,175,366 (-87.96%)

$765,759,617 (-54.25%)

Average Equity

$114,705,500 (-40.15%)

$191,661,250 (-31.64%)

$280,362,250 (-30.50%)

$403,371,000 (82.39%)

Average Assets

$155,409,750 (-37.89%)

$250,228,000 (-24.16%)

$329,920,500 (-26.63%)

$449,677,000 (46.32%)

Invested Capital Average

$94,142,500 (-51.97%)

$196,021,250 (-20.43%)

$246,347,000 (-12.60%)

$281,870,000 (61.51%)

Shares

60,340,918 (3.47%)

58,316,520 (2.49%)

56,898,374 (0.98%)

56,347,286 (0.56%)